Created a new unique method of treating pollinosis New drug therapy will help to permanently end the unpleasant symptoms of pollinosis or hay fever. The study showed that the combination of two immunotherapeutic drugs leads to the desired effect..

London's Royal Brompton Hospital has begun a trial involving 100 people suffering from pollinosis or hay fever - one of the most common allergic disorders in the world.. Its victims face many unpleasant symptoms when pollen is released into the air.. The technique is a combination of two immunotherapy drugs called Grazax and dipilumab, and it could be the ultimate solution to this problem, British researchers believe.. They hope that the treatment, which consists of daily pills and injections every two weeks for two years, will work in four months..

Hay fever is often not taken seriously. It is rather frivolously treated by doctors and relatives of patients who themselves do not experience symptoms of hay fever.. But in reality, this allergy has an extremely unpleasant effect on the quality of life of a person, on school performance and on work efficiency.. Pollinosis disrupts the quality of sleep, prevents people from fully enjoying outdoor recreation, and at the best time of the year.. Hay fever has also been linked to asthma and some life-threatening complications..

Usually, patients with pollinosis are prescribed antihistamines, which block the effect of histamine receptors in the nose and throat.. In more severe cases, corticosteroid nasal sprays are used, but they do not help everyone.. Now scientists believe that the final solution to the problem will be immunotherapy, that is, drugs that teach the immune system to respond correctly to the allergen by blocking the action of certain cells, so that the body of the victim of hay fever will no longer react to pollen in any way..

https://www. medicalforum. en Keywords:.